Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 206-496-7 | CAS number: 350-03-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2015-11-18 - 2015-12-16
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Well-documented GLP OECD guideline study without deviations on the registered substance itself.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 442B (Skin Sensitization: Local Lymph Node Assay: BrdU-ELISA)
- Version / remarks:
- OECD: Guideline for the Testing of Chemicals; Section 4: Health Effects: 442B Skin Sensitization: Local Lymph Node Assay: BrdU-ELISA. Adopted: 22 July 2010
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Ministerium für Arbeit, Integration und Soziales des Landes Nordrhein-Westfalen, Fürstenwall 25, 40219 Düsseldorf, Germany
- Type of study:
- mouse local lymph node assay (LLNA)
- Species:
- mouse
- Strain:
- CBA
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Envigo, 5961 NM Horst, NL
- Age at study initiation: 8-12 weeks
- Weight at study initiation: 17-22 g
- Housing: OP3 (SPF-barrier), In groups of 4 animals in open Eurostandard type III macrolon cages, with Lignocel hygienic animal bedding (J. Rettenmaier & Söhne GmbH + Co. KG, 73494 Rosenberg), heat-treated, Specified pathogen free (SPF) housing with permanent health monitoring by room specific sentinel animals (bedding sentinels) in accordance with FELASA recommendations, with Wooden gnawing blocks, size medium 10 x 2 x 2 cm, debarked, aspen wood, NGM E-022 (ABEDD LAB & VET Service GmbH), heat-treated
- Diet (e.g. ad libitum): Maintenance diet rat/mouse, pellets, No. 1324 TPF (Altromin GmbH & Co. KG, 32791 Lage), ad libitum
- Water (e.g. ad libitum): Sterilized community tap water, ad libitum
- Acclimation period: 8 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 3°C
- Humidity (%): 30-70%
- Air changes (per hr): approx. 15
- Photoperiod (hrs dark / hrs light): artificial lighting, 12 h light/12 h dark
IN-LIFE DATES: From: 2015-11-11 To: 2015-11-24 - Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- 2.5%, 5%, 10%
- No. of animals per dose:
- 4 females / dose group
- Details on study design:
- RANGE FINDING TESTS:
In a pre-study, 3-Acetylpyridine was applied on test animals in doses of 50%, 25% and 10%. 24h after the first application the animals that received the 50% and 25% doses were found dead in their cages. The LD50 for oral intake of 3-Acetylpyridine was specified in a range of 51-57 mg/kg bodyweight in rat. The 50% test item dose equals a test item content of 1250 mg/kg bodyweight. Therefore the test animals died most probably due to test item intoxication. The animal, which received the 10% dose, showed no clinical signs indicating systemic intoxication and showed no skin reaction indicating an excessive local skin irritation. Therefore the 10% suspension was selected as high dose for this study.
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: LLNA: BrdU-ELISA
- Criteria used to consider a positive response: Evaluation criteria according to OECD 442B
For assay validity the following system suitability criteria should be fulfilled:
1) ODVC MEAN: 0,1 ≤ ODVC ≤ 0,2
2) SIVC AVERAGE ≅!1,0
3) SIPC ≥ 1,6 over SIVC*
Classification of SI values is as follows:
SI indicates a positive result when:
1,6 ≤ SI ≤ 1,9 = borderline positive**
2,0 ≤ SI = positive
*No excessive skin irritation or systemic toxicity should be observed in parallel.
**Additional information (such as dose-response relationship, evidence of systemic toxicity or excessive irritation) should be considered to confirm that such results are positives.
TREATMENT PREPARATION AND ADMINISTRATION:
Application
25 μL of the extracted test substance, the vehicle alone or the positive control (PC), were applied to the dorsum of each ear (50 μL per animal) using a tipped pipette. Animals were fixed until evaporation of acetone. In brief, the complete experimental schedule of the assay was as follows:
• Day 1: Individually identify and record the weight of each animal and any clinical observation. Apply 25 μL of the extracted test substance, the vehicle alone or the PC, to the dorsum of each ear.
• Day 2: Repeat the application procedure carried out on day 1.
• Day 3: Repeat the application procedure carried out on day 1.
• Day 4: No treatment.
• Day 5: Inject 0.5 mL (5 mg/mouse) of BrdU2 (10 mg/mL) solution intraperitoneally.
• Day 6: Record the weight of each animal and any clinical observation. To further monitor the local skin response, score an occurring ear erythema approximately 24 h after BrdU injection and humanely kill the animals. Punch both ears and weigh ear punch-pair. Excise the draining auricular lymph nodes from each mouse ear and process separately in phosphate buffered saline for each animal. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- Calculation of results
For each experimental group, a stimulation index (SI) was calculated by dividing the mean BrdU labeling index for each individual animal by the mean BrdU labeling index for thevehicle group (the average SI for the vehicle group is 1).
The BrdU labeling index is defined as:
BrdU labelling index = (OD370nm – OD blank370nm) – (OD492nm – OD blank492nm) - Positive control results:
- Group SI = 4.9 (Medium of 3 replicates, 4.5±0.7, 6.0 ±0.6, 4.2±1.2)
- Parameter:
- SI
- Remarks on result:
- other: S.I. of test group (2.5 %): 1.1±0.4 S.I. of test group (5 %): 1.0±0.3 S.I. of test group (10 %): 1.1±0.3
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: not applicable
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The study was conducted under GLP according to OECD guideline 442B on the registered substance itself. The method is to be considered scientifically reasonable with no deficiencies in documentation or any deviations, the validity criteria are fulfilled, positive and negative controls gave the appropriate response. Hence, the results can be considered as reliable to assess the sensitizing potential of 3-Acetylpyridine in mice. 3-Acetylpyridine did not induce signs of general toxicity. No significantly increased ear thickness, in terms of ear punch weight, was detected. Together with the negligible proliferative responses of the LNCs, 3-Acetylpyridine was identified as a non-sensitizing agent in the Local Lymph Node Assay. Hence, no classification as skin sensitizer is triggered.
- Executive summary:
A dermal sensitization study was carried out according to guideline OECD 442B (Guideline for the Testing of Chemicals; Section 4: Health Effects: 442B Skin Sensitization: Local Lymph Node Assay: BrdU-ELISA) in CBA/Ca mice using 25 % α-Hexylcinnamaldehyde (HCA) as positive control and acetone: olive oil (4:1 v/v) as vehicle. The test item 3-Acetylpyridine was diluted in vehicle solution to receive a 10% suspension (high dose). In a preliminary screen test the 10% test item suspension did not show any signs of systemic intoxication or excessive skin irritation. Therefore the 10% test item suspension was found to be the feasible high dose for this LLNA. In this study the high dose and two subsequent dilutions of 5% and 2,5%, medium and low dose respectively, of the test item were applied to the dorsal side of the ears.
Animals were monitored daily. Determination of cellular proliferation was performed using the BrdU method in reference to the OECD guideline 442B. Additionally, ear thickness was determined through ear punch weight on day 6 of the study.
3-Acetylpyridine did not induce signs of general toxicity. No significantly increased ear thickness, in terms of ear punch weight, was detected. Together with the negligible proliferative responses of the LNCs, 3-Acetylpyridine was identified as a non-sensitizing agent in the Local Lymph Node Assay.
The study was classified as acceptable, and no classification of 3-Acetylpyridine as skin sensitizer is triggered.
Reference
Results
1 Health monitoring
1.1 Fatalities
There were no fatalities or moribund animals.
1.2 General clinical signs and behavior
No abnormalities concerning clinical signs and behavior were observed in the animals of the positive control group, all dose groups or vehicle group, respectively. No signs of general toxicity were observed.
1.3 Body weight
The mean weight at the start of the study (d1) was 20,9 g; the minimum weight was 19,2 g (8% difference to the mean weight), the maximal weight was 22,7 g (8% difference to the mean weight). Therefore the stratification and randomization procedures were sufficient. During the in life phase, the mean body weights and the body weight gains of all experimental animal groups were within normal range for healthy mice of this strain and age.
1.4 Erythema
Approximately 24 hours (24 h) after BrdU injection (day 6), both ears of each mouse were observed for erythema. The animals of the positive control group showed a very slight erythema. In contrast the animals of the dose groups or vehicle group did not show any signs of erythema on day 6.
1.5 Ear punch weight
Ear thickness was determined through ear punch weight at necropsy (day 6).
Ear punch weight [mg]. Asterisks denote significance levels (t-test, two tailed, unpaired): *: 0.05 ≥ p > 0.01; **: 0.01 ≥ p > 0.001; ***: p ≤ 0.001 (n.s.: not significant).
Group |
Pos.-Control, 25% HCA |
3-AP, 10% |
3-AP, 5% |
3-AP, 2.5% |
Vehicle |
|||||
Animal No. |
Box |
Ear punch weight [mg] |
Box |
Ear punch weight [mg] |
Box |
Ear punch weight [mg] |
Box |
Ear punch weight [mg] |
Box |
Ear punch weight [mg] |
1 |
E 990 |
12.7 |
E 991 |
9.4 |
E 992 |
8.4 |
E 993 |
9.9 |
E 994 |
9.4 |
2 |
11.6 |
9.5 |
9.3 |
9.8 |
9.0 |
|||||
3 |
12.3 |
9.7 |
10.2 |
10.5 |
8.8 |
|||||
4 |
12.1 |
10.4 |
10.3 |
10.3 |
9.3 |
|||||
Mean |
12.2 |
|
9.8 |
|
9.6 |
|
10.1 |
|
9,1 |
|
SD |
±0.5 |
±0.5 |
±0.9 |
±0.3 |
±0.3 |
|||||
ttest vs. Veh. p= |
0.000 |
|
0.056 |
|
0.396 |
|
0.004 |
|
|
|
Significance |
*** |
|
n.s. |
|
n.s |
|
** |
|
|
3-AP: 3-Acetylpyridine
Using the two tailed unpaired Student’s t-test, a significantly increased ear punch weight was found for the animals of the positive control (PC) group (p= 0,00003) and for the animals of the low dose group (p=0,004), when compared to the vehicle group. The animals of the PC group showed also a very slight erythema and a stimulation of the LCN’s. The slight erythema and the stimulation of the LCN`s were regarded as signs of sensitization. No such correlates were found for the animals of the low dose group in this regard. Therefore the increase of ear thickness in the low dose group is most probably not due to a sensitizing reaction. An increase of ear thickness due to a skin irritating effect in the absence of erythema or eschar is highly unlikely. No significant difference in ear punch weight was found for the animals of the high (P= 0,609) and medium (P= 0,396) dose groups, when compared to the vehicle group, respectively.
2 Determination of cellular proliferation (BrdU ELISA)
The content of BrdU, incorporated into the DNA of proliferating lymphnodes, was measured by ELISA, using a commercial kit. Using this non- radioactive assay, results were calculated appropriately for those method as described in the OECD series 442B. In brief, a stimulation index of 2,0 or higher clearly identifies a test item as a sensitizer, whereas an SI between 1,6 and 1,9 is considered as a borderline positive response where additional information (such as dose-response relationship, evidence of systemic toxicity or excessive irritation) should be used to confirm that such a result is true positive.
2.1 Validity of the assay
The mean absorbance value of the vehicle groups (ODVC MEAN) at a sample volume of 10,0 mL was 0,108 (0,118; 0,092 and 0,114 for the three test plates) and therefore within the assay’s acceptance range of ODVC MEAN 0,1 to 0,2. The positive control groups (PC) at 10 mL yielded SI’s ≥ 2,0, which are considered as true positive results, therefore, the assay is considered to be valid.
2.2 Proliferation of LNCs
In order to assess the sensitizing potential of 3-Acetylpyridine in high, medium and low dose, respectively, a sample volume of 10 mL at an incubation time of 30 minutes was chosen for calculation of the results
High dose group: Proliferation of LNCs in terms of BrdU incorporation.Individual BrdU labeling indices, group means of BrdU labeling indices and Stimulation Indices (SI) ± SD are given for the 10 mL sample volume.
Group |
BrdU labeling indices/ animal |
Group mean SD |
Group SI SD |
|||
pos-Contr., 25% HCA |
E 990/0 |
E 990/1 |
E 990/2 |
E 990/3 |
0.531 ± 0.055 |
4.5 ± 0.7 |
0.648 |
0.492 |
0.474 |
0.509 |
|||
High dose, 3-Acetylpyridine |
E 991/0 |
E 991/1 |
E 991/2 |
E 991/3 |
0.132 ± 0.035 |
1.1 ± 0.3 |
0.099 |
0.180 |
0.132 |
0.116 |
|||
Vehicle, Acetone: olive oil (4:1 v/v) |
E 994/0 |
E 994/1 |
E 994/2 |
E 994/3 |
0.118 ± 0.034 |
1.0 ± 0.3 |
0.160 |
0.123 |
0.110 |
0.078 |
Medium dose group: Proliferation of LNCs in terms of BrdU incorporation.Individual BrdU labeling indices, group means of BrdU labeling indices and Stimulation Indices (SI) ± SD are given for the 10 mL sample volume.
Group |
BrdU labeling indices/ animal |
Group mean SD |
Group SI SD |
|||
pos-Contr., 25% HCA |
E 990/0 |
E 990/1 |
E 990/2 |
E 990/3 |
0.556 ± 0.055 |
6.0 ± 0.6 |
0.613 |
0.539 |
0.488 |
0.585 |
|||
Medium dose, 3-Acetylpyridine |
E 992/0 |
E 992/1 |
E 992/2 |
E 992/3 |
0.097 ± 0.026 |
1.0 ± 0.3 |
0.130 |
0.097 |
0.066 |
0.093 |
|||
Vehicle, Acetone: olive oil (4:1 v/v) |
E 994/0 |
E 994/1 |
E 994/2 |
E 994/3 |
0.092 ± 0.030 |
1.0 ± 0.3 |
0.131 |
0.101 |
0.070 |
0.068 |
Low dose group: Proliferation of LNCs in terms of BrdU incorporation.Individual BrdU labeling indices, group means of BrdU labeling indices and Stimulation Indices (SI) ± SD are given for the 10 mL sample volume.
Group |
BrdU labeling indices/ animal |
Group mean SD |
Group SI SD |
|||
pos-Contr., 25% HCA |
E 990/0 |
E 990/1 |
E 990/2 |
E 990/3 |
0.480 ± 0.137 |
4.2 ± 1.2 |
0.460 |
0.358 |
0.427 |
0.675 |
|||
Low dose, 3-Acetylpyridine |
E 993/0 |
E 993/1 |
E 993/2 |
E 993/3 |
0.125 ± 0.047 |
1.1 ± 0.4 |
0.065 |
0.116 |
0.144 |
0.175 |
|||
Vehicle, Acetone: olive oil (4:1 v/v) |
E 994/0 |
E 994/1 |
E 994/2 |
E 994/3 |
0.114 ± 0.031 |
1.0 ± 0.3 |
0.091 |
0.098 |
0.109 |
0.160 |
In the Local Lymph Node Assay, the application of 3-Acetylpyridine in the high, medium and low dose led to the following stimulation indexes (SI’s):
Summary of SI’s of experimental dose groups.
Groups |
% 3-AP |
SI |
High dose |
10.0 |
1.1 ± 0.3 |
Medium dose |
5.0 |
1.0 ± 0.3 |
Low dose |
2.5 |
1.1 ± 0.4 |
In conjunction with the absence of evidence of systemic toxicity or irritation the proliferative responses of the LNCs in the high, medium and low dose groups were regarded to be negligible in terms of sensitization.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
There is a valid GLP OECD 442B guideline study available to cover this endpoint. Hence, the database is of good quality. 3-Acetylpyridine did not induce signs of general toxicity. No significantly increased ear thickness, in terms of ear punch weight, was detected. Together with the negligible proliferative response of the lymph node cells (LNCs), the test item 3-Acetylpyridine was identified as a non-sensitizing agent in the Local Lymph Node Assay.
There is no indication given that the result is not relevant for human risk assessment, even though no human data is available, as all tested concentrations gave a clear negative result. The tonnage-driven data requirements under REACH are fully met, no data gaps were identified.
Migrated from Short description of key information:
Skin sensitization: Local Lymph nose assay, CBA/Ca mice, female, 2.5%, 5%, 10% in acetone: olive oil (4:1 v/v), OECD 442B, GLP: not sensitizing
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
In the available valid GLP OECD 442B guideline study, 3-Acetylpyridine did not induce signs of general toxicity. No significantly increased ear thickness, in terms of ear punch weight, was detected. Together with the negligible proliferative response of the lymph node cells (LNCs), the test item 3-Acetylpyridine was identified as a non-sensitizing agent in the Local Lymph Node Assay, so no classification as skin sensitizer is triggered.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.